GO:0017187 | peptidyl-glutamic acid carboxylation | 1.48e-05 | 2.13e-01 | 8.357 | 2 | 2 | 11 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.09e-05 | 3.02e-01 | 8.116 | 2 | 2 | 13 |
GO:0004252 | serine-type endopeptidase activity | 2.10e-05 | 3.03e-01 | 5.673 | 3 | 3 | 106 |
GO:0042730 | fibrinolysis | 4.10e-05 | 5.91e-01 | 7.646 | 2 | 3 | 18 |
GO:0045861 | negative regulation of proteolysis | 4.10e-05 | 5.91e-01 | 7.646 | 2 | 4 | 18 |
GO:0044212 | transcription regulatory region DNA binding | 8.33e-05 | 1.00e+00 | 5.009 | 3 | 17 | 168 |
GO:0009611 | response to wounding | 3.52e-04 | 1.00e+00 | 6.116 | 2 | 5 | 52 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0005796 | Golgi lumen | 6.75e-04 | 1.00e+00 | 5.646 | 2 | 3 | 72 |
GO:0006508 | proteolysis | 9.07e-04 | 1.00e+00 | 3.839 | 3 | 6 | 378 |
GO:0060242 | contact inhibition | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0007596 | blood coagulation | 1.55e-03 | 1.00e+00 | 3.571 | 3 | 11 | 455 |
GO:0050900 | leukocyte migration | 1.57e-03 | 1.00e+00 | 5.035 | 2 | 2 | 110 |
GO:0060279 | positive regulation of ovulation | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0005654 | nucleoplasm | 1.73e-03 | 1.00e+00 | 2.737 | 4 | 64 | 1082 |
GO:0044267 | cellular protein metabolic process | 1.75e-03 | 1.00e+00 | 3.512 | 3 | 20 | 474 |
GO:0070053 | thrombospondin receptor activity | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0003677 | DNA binding | 2.68e-03 | 1.00e+00 | 2.566 | 4 | 49 | 1218 |
GO:0005788 | endoplasmic reticulum lumen | 2.70e-03 | 1.00e+00 | 4.636 | 2 | 5 | 145 |
GO:0001714 | endodermal cell fate specification | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 2 | 5 |
GO:0014909 | smooth muscle cell migration | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0006974 | cellular response to DNA damage stimulus | 2.93e-03 | 1.00e+00 | 4.578 | 2 | 7 | 151 |
GO:0031639 | plasminogen activation | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0043687 | post-translational protein modification | 3.36e-03 | 1.00e+00 | 4.476 | 2 | 5 | 162 |
GO:0003714 | transcription corepressor activity | 4.04e-03 | 1.00e+00 | 4.340 | 2 | 11 | 178 |
GO:0001955 | blood vessel maturation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0006983 | ER overload response | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0010544 | negative regulation of platelet activation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0030194 | positive regulation of blood coagulation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0051918 | negative regulation of fibrinolysis | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0045662 | negative regulation of myoblast differentiation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0030195 | negative regulation of blood coagulation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0048712 | negative regulation of astrocyte differentiation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0008134 | transcription factor binding | 7.34e-03 | 1.00e+00 | 3.897 | 2 | 18 | 242 |
GO:0030193 | regulation of blood coagulation | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0007597 | blood coagulation, intrinsic pathway | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 18 |
GO:0051480 | cytosolic calcium ion homeostasis | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 18 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 3 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 20 |
GO:0005515 | protein binding | 1.12e-02 | 1.00e+00 | 1.067 | 7 | 198 | 6024 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 3 | 21 |
GO:0005576 | extracellular region | 1.21e-02 | 1.00e+00 | 2.521 | 3 | 13 | 942 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 2 | 23 |
GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 24 |
GO:0006355 | regulation of transcription, DNA-templated | 1.42e-02 | 1.00e+00 | 2.440 | 3 | 43 | 997 |
GO:0035329 | hippo signaling | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 26 |
GO:0043565 | sequence-specific DNA binding | 1.46e-02 | 1.00e+00 | 3.381 | 2 | 11 | 346 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0048167 | regulation of synaptic plasticity | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 30 |
GO:0044822 | poly(A) RNA binding | 1.66e-02 | 1.00e+00 | 2.357 | 3 | 50 | 1056 |
GO:0042594 | response to starvation | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 4 | 31 |
GO:0035249 | synaptic transmission, glutamatergic | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 3 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 2 | 32 |
GO:0006953 | acute-phase response | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 35 |
GO:0009986 | cell surface | 1.94e-02 | 1.00e+00 | 3.165 | 2 | 9 | 402 |
GO:0035019 | somatic stem cell maintenance | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 6 | 40 |
GO:0051591 | response to cAMP | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 4 | 45 |
GO:0043434 | response to peptide hormone | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 5 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 4 | 46 |
GO:0006986 | response to unfolded protein | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 51 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 51 |
GO:0006396 | RNA processing | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 5 | 59 |
GO:0000786 | nucleosome | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 2 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 6 | 59 |
GO:0005509 | calcium ion binding | 3.27e-02 | 1.00e+00 | 2.764 | 2 | 11 | 531 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 2 | 61 |
GO:0030141 | secretory granule | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 4 | 62 |
GO:0010468 | regulation of gene expression | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 68 |
GO:0030307 | positive regulation of cell growth | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 2 | 69 |
GO:0006334 | nucleosome assembly | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 3 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0045177 | apical part of cell | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 3 | 81 |
GO:0009653 | anatomical structure morphogenesis | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 2 | 83 |
GO:0006464 | cellular protein modification process | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 4 | 84 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 8 | 86 |
GO:0001649 | osteoblast differentiation | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 5 | 92 |
GO:0010467 | gene expression | 4.99e-02 | 1.00e+00 | 2.430 | 2 | 45 | 669 |
GO:0005770 | late endosome | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 93 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.41e-02 | 1.00e+00 | 2.367 | 2 | 39 | 699 |
GO:0008360 | regulation of cell shape | 5.57e-02 | 1.00e+00 | 4.130 | 1 | 4 | 103 |
GO:0001934 | positive regulation of protein phosphorylation | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 5 | 104 |
GO:0072562 | blood microparticle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 5 | 112 |
GO:0007050 | cell cycle arrest | 6.68e-02 | 1.00e+00 | 3.862 | 1 | 5 | 124 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.72e-02 | 1.00e+00 | 2.192 | 2 | 41 | 789 |
GO:0005634 | nucleus | 7.14e-02 | 1.00e+00 | 0.984 | 5 | 159 | 4559 |
GO:0045202 | synapse | 7.30e-02 | 1.00e+00 | 3.729 | 1 | 5 | 136 |
GO:0016055 | Wnt signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 4 | 138 |
GO:0008083 | growth factor activity | 7.56e-02 | 1.00e+00 | 3.677 | 1 | 3 | 141 |
GO:0007166 | cell surface receptor signaling pathway | 7.87e-02 | 1.00e+00 | 3.616 | 1 | 4 | 147 |
GO:0001666 | response to hypoxia | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 7 | 149 |
GO:0031012 | extracellular matrix | 8.23e-02 | 1.00e+00 | 3.549 | 1 | 6 | 154 |
GO:0000398 | mRNA splicing, via spliceosome | 8.74e-02 | 1.00e+00 | 3.459 | 1 | 15 | 164 |
GO:0005667 | transcription factor complex | 9.31e-02 | 1.00e+00 | 3.365 | 1 | 17 | 175 |
GO:0005615 | extracellular space | 9.43e-02 | 1.00e+00 | 1.914 | 2 | 20 | 957 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.76e-02 | 1.00e+00 | 3.293 | 1 | 22 | 184 |
GO:0030168 | platelet activation | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 6 | 205 |
GO:0008380 | RNA splicing | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 22 | 228 |
GO:0003713 | transcription coactivator activity | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 24 | 237 |
GO:0005102 | receptor binding | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 2 | 260 |
GO:0005829 | cytosol | 1.47e-01 | 1.00e+00 | 1.116 | 3 | 86 | 2496 |
GO:0007275 | multicellular organismal development | 1.62e-01 | 1.00e+00 | 2.512 | 1 | 7 | 316 |
GO:0008283 | cell proliferation | 1.68e-01 | 1.00e+00 | 2.459 | 1 | 14 | 328 |
GO:0003723 | RNA binding | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 18 | 342 |
GO:0046982 | protein heterodimerization activity | 1.92e-01 | 1.00e+00 | 2.246 | 1 | 8 | 380 |
GO:0008284 | positive regulation of cell proliferation | 1.93e-01 | 1.00e+00 | 2.239 | 1 | 10 | 382 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.07e-01 | 1.00e+00 | 2.126 | 1 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.10e-01 | 1.00e+00 | 2.105 | 1 | 30 | 419 |
GO:0043066 | negative regulation of apoptotic process | 2.12e-01 | 1.00e+00 | 2.088 | 1 | 16 | 424 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.36e-01 | 1.00e+00 | 1.915 | 1 | 24 | 478 |
GO:0005737 | cytoplasm | 3.49e-01 | 1.00e+00 | 0.522 | 3 | 124 | 3767 |
GO:0070062 | extracellular vesicular exosome | 3.95e-01 | 1.00e+00 | 0.587 | 2 | 57 | 2400 |
GO:0005886 | plasma membrane | 4.34e-01 | 1.00e+00 | 0.482 | 2 | 49 | 2582 |
GO:0005524 | ATP binding | 5.30e-01 | 1.00e+00 | 0.474 | 1 | 31 | 1298 |
GO:0005730 | nucleolus | 6.20e-01 | 1.00e+00 | 0.136 | 1 | 66 | 1641 |
GO:0016020 | membrane | 6.29e-01 | 1.00e+00 | 0.101 | 1 | 46 | 1681 |